Real Heart (Sweden) Insiders

HEART Stock  SEK 13.70  0.10  0.74%   
Real Heart employs about 8 people. The company is managed by 4 executives with a total tenure of roughly 19 years, averaging almost 4.0 years of service per executive, having 2.0 employees per reported executive. For Real Heart, management analysis can help investors test whether leadership decisions are reinforcing the broader investment thesis or creating new operating risk. Used properly, management analysis helps separate durable execution from results that may only reflect a supportive market cycle.
Ina Perkins  Insider
MD CEO
Azad Najar  Insider
Chief Founder
  
Risk vs Return Analysis provides context for diversified portfolio design. Such insight adds context to allocation decisions within a diversified portfolio. The allocation includes a position in Real Heart within the portfolio mix. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population.

Real Heart Management Team Effectiveness

The company has return on total asset (ROA) of -7.75 % which means that it has lost $7.75 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of -14.47 %, meaning that it generated substantial loss on money invested by shareholders.

Real Stock Ownership Analysis

About 26.0% of the company shares are held by company insiders. The company has price-to-book (P/B) ratio of 0.85. Some equities with similar Price to Book (P/B) outperform the market in the long run. Real Heart recorded a loss per share of 0.32. The entity had not issued any dividends in recent years. The firm completed a 100:1 stock split on 21st of November 2024.

Real Heart Outstanding Bonds

Reviewing Real Heart bond obligations helps investors understand how much of the business is financed with fixed-income capital rather than purely with equity. This is why bond analysis is not just a credit exercise; it also informs equity holders about solvency, optionality, and future capital-allocation pressure.
Real Heart records a substantial amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Institutional investors hold approximately 3% of Real Heart's outstanding shares, with insiders holding 26% and 70% in the public float.

Real Stock Holders Distribution

Institutional ownership analysis for Real Heart matters because banks, hedge funds, pension plans, and other professional investors can influence price and liquidity more forcefully than smaller holders. This matters because getting in early on a sponsorship cycle may help, but getting caught near a large-holder exit can have the opposite effect.

Real Heart Workforce Comparison

Real Heart is positioned as one of the top stocks in number of employees category among its top compatitors. The total workforce of Medical Devices industry is currently estimated at about 84.0. Real Heart holds roughly 8.0 in number of employees claiming about 10% of all equities under Medical Devices space.

Real Heart Benchmark Summation

Operator
The output start index for this execution was zero with a total number of output elements of sixty-one. Real Heart Price Series Summation is a cross summation of Real Heart price series and its benchmark/peer.

Real Heart Notable Stakeholders

Stakeholders matter for Real Heart because not every influential participant is a shareholder acting with the same objective or time horizon. This becomes more informative when investors want to understand not just ownership, but influence, incentives, and strategic pressure points.

Real Heart Leadership and Employee Trends

Real Heart is a micro-cap company. Executive review focuses on insiders, senior management, and employee signals. Organizational trends can support analysis of efficiency, oversight, and decision-making consistency. Real Heart is assessed in terms of its structural contribution to portfolio diversification and long-term stability.

Methodology

Unless otherwise specified, financial data for Real Heart is derived from periodic company reporting (annual and quarterly where available). Asset-level metrics are computed daily by Macroaxis LLC and refreshed regularly based on asset type. Real (SE:HEART) prices are typically delayed by approximately 20 minutes from primary exchanges for listed equities. Data may be delayed depending on reporting sources and market conventions Insider activity and ownership figures are derived from regulatory filings, including SEC Form 4 submissions where applicable.

Assumptions

Underlying inputs rely on public filings and market reference sources, including disclosures from U.S. Securities and Exchange Commission (SEC) via EDGAR. Values may reflect publication timing differences. All analytics are generated using standardized, rules-based models designed to promote consistency and comparability across instruments. Model assumptions, reference parameters, and selected computational inputs are available in the Model Inputs section. If you have questions about our data sources or methodology, please contact Macroaxis Support.

Analyst Sources

Real Heart may have analyst coverage included in Macroaxis-derived consensus inputs when available. Updates may occur throughout the day.

Real Heart Workforce Analysis

Investors reviewing Real Heart can use workforce efficiency as another lens on execution, especially when comparing similar businesses in the same industry. A disciplined workforce review can reveal whether execution quality is improving beneath the top-line numbers.

Real Heart Manpower Efficiency

Return on Real Heart Manpower

Revenue Per Employee0.0
Revenue Per Executive0.0
Net Loss Per Employee1.3M
Net Loss Per Executive2.6M
Working Capital Per Employee375K
Working Capital Per Executive750K

Additional Tools for Real Stock Analysis

Equity Valuation
Check real value of public entities based on technical and fundamental data
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Portfolio Holdings
Check your current holdings and cash position to determine if your portfolio needs rebalancing
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Stocks Directory
Find actively traded stocks across global markets
Share Portfolio
Track or share privately all of your investments from the convenience of any device